#85 Long-term outcomes of artificial urinary sphincter in male patients with spina bifida

Presenter: Benoit Peyronnet

#86 Evaluation of pulse width of spinal nerve stimulation in a rat model of bladder micturition reflex

Presenter: Xin Su

#87 The development of aberrant bladder reflexes that drive hind limb locomotor activity following complete suprasacral spinal cord injury

Presenter: Matthew O Fraser

#88 EVALUATION OF THE LOWER URINARY TRACT FUNCTIONS IN DIABETIC PATIENTS WITH OR WITHOUT DIABETIC NEUROPATHY

Presenter: Umit Eskidemir

#89 Non-continent urinary diversion (ileal conduit) as a salvage therapy in patients with refractory lower urinary tract dysfunctions due to multiple sclerosis: preliminary results of a national cohort study.

Presenter: Gilles Karsenty

#90 The effect of subthalamic nucleus deep brain stimulation on lower urinary tract symptoms in patients with Parkinson’s disease

Presenter: Tatsuya Yamamoto

#91 The effect and mechanism of change in neuroreceptors in the bladder and skin with ovarectomised rats.

Presenter: Tetsuichi Saito

#92 THE RELATIONSHIP BETWEEN LOWER URINARY TRACTFUNCTION AND 123I- IOFLUPANE SCINTIGRAPHYIN PARKINSON’S DISEASE.

Presenter: Fuyuki Tateno

#93 Protective effect of tadalafil on endothelial function of bladder microvessels in a rat model of chronic bladder ischemia

Presenter: Masanori Nomiya

#94 Intermittent sacral root neuromodulation (ISRN): a novel therapy for the treatment of chronic pelvic pain syndrome (CPPS)

Presenter: Maria Angela Cerruto

#95 Comparison of neurogenic lower urinary tract dysfunctions in open vs. closed spinal dysraphism : results observed in a prospective cohort of 395 patients

Presenter: Benoit Peyronnet

#96 Urinary symptoms and associated factors in Parkinson's Disease

Presenter: Marilena Gubbiotti

#97 Is Radiation exposure during sacral neuromodulation within safety limits?

Presenter: Ali Alabbad

#98 ROTIGOTINE EFFECTS ON BLADDER FUNCTION OF PARKINSON’S DISEASE

Presenter: Valerio Iacovelli

#99 EFFECTS OF GROUP III METABOTROPIC GLUTAMATE RECEPTOR AGONIST ON THE MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS

Presenter: Masashi Honda

#100 ARE ANTIMUSCARINICS REALLY EFFECTIVE IN SPINAL CORD INJURY (SCI) PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY (NDO)?

Presenter: Daniele Bianchi

#101 Is there any significance of the appearance of the urethral pressure profile trace in women with voiding dysfunction?

Presenter: Neha Sihra

#102 Long-term urodynamic follow-up after external sphincterotomy in patients with spinal cord injury

Presenter: Ryosuke Takahashi

#103 Sacral neuromodulation tined lead migration rate at 5 years post-implant

Presenter: Tomas Griebling

#104 Interaction with the peers improves the probability of acceptance of onabotulinum toxin A treatment in spinal cord injured (SCI) patients –an Indian experience.

Presenter: Dinesh Suman

#105 Recovery of bladder and bowel fullness sensation by nerve transfer in a canine decentralized bladder model

Presenter: Ekta Tiwari

#106 Lower urinary tract symptoms and sexual dysfunction in people with multiple sclerosis

Presenter: Katarina Ivana Tudor

#107 Macroplastique and Botox are superior to Macroplastique alone in the management of neurogenic vesicoureteric reflux in spinal cord injury population in presumed healthy bladders.

Presenter: Vasileios Sakalis

#108 Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.

Presenter: Véronique Phé

#109 High prevalence of detrusor overactivity with impaired contractile function in patients with idiopathic normal pressure hydrocephalus

Presenter: Seiji Aruga

#110 Could we use less injection sites of onabotulinumtoxinA in re-treatments with the same efficacy? Preliminary results of a pilot study

Presenter: Esther Martinez-Cuenca

#111 Long-term Follow-up of Augmentation Enterocystoplasty for Neurogenic Bladder Dysfunction

Presenter: Sender Herschorn

#112 Tadalafil attenuates hypotonicity-induced Ca2+ influx via TRPV2 and TRPV4 channels as well as ATP release in primary bladder urothelial cell cultures.

Presenter: Hiroshi Nakagomi

#113 Chronic spinal cord injury causes up-regulation of serotonin (5-HT) 2A and 2C receptors in lumbosacral cord motoneurons

Presenter: Baojun Gu

#114 Heterogeneity in reporting on urinary outcome and cure after surgical interventions for stress urinary incontinence in adult neuro-urological patients: a systematic review.

Presenter: Sarah H M Reuvers

#115 Early application of clean intermittent catheterization in children with neurogenic bladder

Presenter: Jian Guo Wen

#116 Reconstruction of bladder function and prevent renal deteriorate by end-to-side neurorrhaphy in rats with neurogenic bladder

Presenter: Jian Guo Wen

#117 Temporal changes in bladder function in an animal model of Parkinson’s disease

Presenter: Maryrose P Sullivan

#118 Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy

Presenter: Sung Kyu Hong

#119 Effects of Tamsulosin in Neurogenic Voiding Dysfunction in Rat Model

Presenter: Heung Jae Park

#120 Efficacy and safety of Mirabegron as an add-on therapy in patients with neurogenic detrusor overactivity resistant to monotherapy with antimuscarinics.

Presenter: Athanassios Oeconomou

#121 Clinical and Urodynamic changes post Onabotulinum Toxin-A treatment in adults with Spina Bifida.

Presenter: Sandra Elmer

#122 Beneficial effects of quercetin on rat urinary bladder after cisplatinum treatment

Presenter: Ilker Tinay

#123 ON LABLE TREATMENT OF INTRADETRUSOR BOTULINIUM TOXIN IS LESS EFFECTIVE THAN PREVIOUS USED OFF LABEL DOSAGES

Presenter: Michele Spinelli

#124 Relationship between bladder, periarterial and somatic neuropathy in diabetes

Presenter: Ryuji Sakakibara

#125 Dutch translation and validation of the SF-Qualiveen, a urinary-specific quality of life measure, in Multiple Sclerosis and Spinal Cord Injury patients.

Presenter: Sarah H M Reuvers

#126 Parkinson’s disease and prostate hyperplasia: which is more contributing to overactive bladder?

Presenter: Ryuji Sakakibara

#127 Bladder first-sensation-volume increase is primary in diabetic neuropathy: a five-grade measure

Presenter: Ryuji Sakakibara

#128 Changing Spinal Cord Injury epidemiology – an impact on bladder management in real life conditions

Presenter: Gabriele Righi

#129 Outcomes of Intradetrusor OnabotulinumtoxinA Injection in Adults with Congenital Spinal Dysraphism in Tertiary Transitional Urology Clinic

Presenter: Rose Khavari

#130 The use of Mirabegron in the treatment of overactive bladder in patients affected by Parkinson's Disease

Presenter: Marilena Gubbiotti

#131 Bladder management, patient satisfaction and complications in spinal cord injured patients after augmentation enterocystoplasty – A long-term follow-up

Presenter: Shu-Yu Wu

#132 Ischial-urethral fistulas in neurogenic patients performing clean intermittent self-catheterization: a single center experience of a rare complication

Presenter: Enrico Ammirati

#133 The efficacy of hyperbaric oxygen treatment for rodent interstitial cystitis/painful bladder syndrome model

Presenter: Akinori Minami

#134 The Natural History of Acute and Chronic Radiation Induced Bladder Dysfunction in a Rat Model of Radiation Cystitis

Presenter: Amy D Dobberfuhl

#135 ASSOCIATION OF URINARY INCONTINENCE AND HYPERTONIC PELVIC FLOOR MUSCLES: A PILOT STUDY TREATING WOMEN WITH VESTIBULODYNIA

Presenter: Marcela Bardin

#136 YOUNG AND SEXUAL ACTIVE WOMEN WITH ACUTE PYELONEPHRITIS: AN OBSERVATIONAL STUDY

Presenter: Matteo Balzarro

#137 The Effectiveness of CBT in the Treatment of Female Sexual Dysfunctions: A qualitative study

Presenter: Ana Paula Pitiá Barreto

#138 THE EFFECTS OF TREATMENT MODALITIES ON QUALITY OF LIFE AND SEXUAL FUNCTION IN TYPES OF URINARY INCONTINENCE

Presenter: Kadriye Nilay Özcan

#139 Does the involvement of pelvic floor muscles differ in primary and secondary provoked vestibulodynia?

Presenter: Mélanie Morin

#140 Intravesical treatment of polysaccharide alginate/collagen gel in a swine model of ketamine cystitis

Presenter: En Meng

#141 Histopathological characteristics of ketamine-associated uropathy and their clinical Association

Presenter: Hueih-Ling Ong

#142 CULTURAL ADAPTATION AND VALIDATION OF THE SPANISH VERSION OF THE FEMALE SEXUAL FUNCTION INDEX (FSFI) IN WOMEN WITH PELVIC FLOOR DISORDERS

Presenter: Beatriz Sanchez

#143 THE FIRST RANDOMIZED CONTROLLED TRIAL COMPARING LASER AND TOPICAL STEROID TREATMENTS FOR LICHEN SCLEROSUS ET ATROPHICUS, PRELIMINARY RESULTS

Presenter: Urska Bizjak-Ogrinc

#144 Significant reduction in pain and lower urinary tract symptoms after removal of incontinence mesh.

Presenter: Rajvinder Khasriya

#145 What are the long term consequences of recreational Ketamine misuse on the urinary tract?

Presenter: Neha Sihra

#146 Physiotherapy Interventions for the Treatment of Urologic Chronic Pelvic Pain Syndrome: A Systematic Review

Presenter: Claudia Hacad

#147 Comparison between Preoperative and Postoperative Sexual Function of the Japanese Women Who Underwent Transvaginal Minimal Mesh Surgery for the Treatment of Pelvic Organ Prolapse

Presenter: Akiko Fujisaki

#148 Outcomes of Trigger Point Release Treatment in Patients with Chronic Pelvic Pain - A Novel Retrospective Study in an Asian Population

Presenter: Zhaolong Deng

#149 TREATMENT WITH INSTILLATION OF HYALURONIC ACID IN PATIENTS WITH A HISTORY OF PELVIC RADIATION THERAPY AND URINARY STORAGE SYMPTOMS

Presenter: Argimiro Collado Serra

#150 Impact of the situation on the waiting list for heart transplantation on the sexual function of male patients in Western Andalusia (Spain).

Presenter: Carmen Maria Suárez-Serrano

#151 The efficacy of OPD based-pudendal nerve block in the Treatment of chronic pelvic pain.

Presenter: Dong Soo Park

#152 CORRELATION BETWEEN BLADDER UROTHELIAL THICKNESS AND CLINICAL SYMPTOMS IN PATIENTS WITH INTERSTITIAL CYSTITIS / BLADDER PAIN SYNDROME (IC/BPS)

Presenter: Ming Huei Lee

#153 The prevalence of bladder pain syndrome in Korea

Presenter: Hyung Jee Kim

#154 TRPV4 receptor activation in the bladder improves voiding dysfunction in a rat model of detrusor underactivity induced by pelvic nerve crush injury

Presenter: Eiichiro Takaoka

#155 Intravesical gemcitabine treatment induces bladder overactivity in mice that is associated with an enhanced urothelial release of ATP and PGE2

Presenter: Russ Chess-Williams

#156 The Effect of ASP6432, a Novel Type 1 Lysophosphatidic Acid Receptor Antagonist, on Urethral Function and Prostate Cell Proliferation

Presenter: Kazuyuki Sakamoto

#157 Hydrogen sulfide can be an endogenous relaxation factor in the rat bladder and prostate

Presenter: Takahiro Shimizu

#158 Anti-cancer agent, oxaliplatin, shortens voiding function and weakens detrusor muscle contraction in rats

Presenter: Tomoya Kataoka

#159 CENTRAL AND PERIFERIC PROSTATE DIFFUSION OF Fosfomycin trometamol in men with or without metabolic abnormalities

Presenter: Omar Saleh

#160 In vivo demonstration of muscarinic receptor selectivity of fesoterodine active metabolite, 5-hydroxymethl tolterodine (5-HMT), in rat tissue

Presenter: Yoshihiko Ito

#161 Connexins 43 and 45 hemichannels and CALHM1 mediate ATP release in human urothelial RT4 cells

Presenter: Hafiz Sana-Ur-Rehman

#162 The effects of flexible-dose tamsulosin on lower urinary tract symptoms and treatment satisfaction in patients with benign prostatic hyperplasia: 12-week, open-label, observational study

Presenter: SunWook Kim

#163 Tadalafil improves urethral function in diabetic rats

Presenter: Daisuke Gotoh

#164 Nobiletin, a flavone from shekwasha (Citrus depressa), alleviates hypertensive bladder response in cyclophosphamide-induced cystitis rats.

Presenter: Yoshihiko Ito

#165 RISK FACTOR AFFECTING RECURRENCE OF CYSTITIS AFTER URO-VAXOM TREATMENT FOR FEMALE PATIENTS WITH RECURRENT CYSTITIS

Presenter: Young-Suk Lee

#166 suture to close part of the urinary meatus: a novel animal model of bladder outlet obstruction

Presenter: Chen Lin

#167 Electron microscopic investigation of interstitial cystitis and KC: ulcer vs non-ulcer IC and their clinical correlation

Presenter: Cheng-Ling Lee

#168 Performance Validation of an Autonomous 12-Channel 100-Gram Load Cell Sensor Array for the Longitudinal Assessment of Rat Bladder Function

Presenter: Amy D Dobberfuhl

#169 Human urinary bladder organoids: a new tool for urothelium study

Presenter: Victor Tostivint

#170 Intravesical volume in mice can continuously and accurately be measured using video-cystometry.

Presenter: Jan Franken

#171 Development and optimisation of a novel 3D fiber-based mesh for POP repair and regeneration

Presenter: Elena Mancuso

#172 Can the method of digitation predict pathology in anorectal dysfunction patients? The case of the scooper, splinter, stretcher and reducer - preliminary data.

Presenter: Samantha Morris

#173 Relationship between urodynamic findings and bowel function in multiple sclerosis patients with lower urinary tract dysfunction: Results from an Italian Cross-Sectional Study

Presenter: Raffaele Balsamo

#174 Prospective Evaluation of Peristeen® Transanal Irrigation System in Multiple Sclerosis patients: Results from an Italian single centre study

Presenter: Raffaele Balsamo

#175 Are we getting better at diagnosing, treating, and managing obstetric anal sphincter injuries (OASIS)?

Presenter: Vered Eisenberg

#176 Peristeen transanal irrigation system for the treatment of neurogenic bowel dysfunction and abdominal pain

Presenter: Giovanni Palleschi

#177 Pelvic floor function in patients presenting with anal fissure.

Presenter: Danielle van Reijn- Baggen

#178 Prevalence and predictors of anal incontinence 6 years after first delivery

Presenter: Hege Johannessen

#179 Therapeutic effect of electro-acupuncture treatment to patients with fecal incontinence who have poor improvement after 6 months of conventional conservative treatment: a pilot study.

Presenter: Fung Ping, Jess Li

#180 The implications of urinary tract reconstruction on pregnancy

Presenter: Neha Sihra

#181 Role of the Urinary Bladder in Water Metabolism—How Does the Bladder Absorb Urine?

Presenter: Yosuke Morizawa

#182 Prevalence and associated factors of Incontinence Associated Dermatitis in hospitalized adults with cancer.

Presenter: Vera Lúcia Conceição de Gouveia Santos

#183 DEVELOPMENT OF A TUTORIAL TYPE SOFTWARE BASED ON SCANNED PHYSICAL SYNTHETIC FEMALE PELVIC FLOOR

Presenter: Paulo Palma

#184 The possibility of urine microRNAs as a predictive biomarker for treating male LUTS/BPH with phosphodiesterase type 5 inhibitors

Presenter: Tomoaki Tanaka

#185 THE URINARY MICROBIOME IN WOMEN WITH MIXED URINARY INCONTINENCE

Presenter: Holly E Richter

#186 Validity of clinical assessment tools to evaluate involuntary pelvic floor muscle contractions during coughing

Presenter: Jacqueline de Jong

#187 Mechanistic evidence to support the use of combination therapy to better manage the treatment of LUTS associated with BPH

Presenter: Betty Exintaris

#188 Target-based 3D stress MRI measurement technique for apical, paravaginal and hiatal changes after surgery for anterior/apical prolapse

Presenter: Luyun Chen

#189 Changes in urinary bladder reactivity in multiparous and ovariectomized female rats submitted to resistance exercise

Presenter: Monica Sato

#190 Video-urodynamic predictive factors of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity

Presenter: Chun-Hou Liao

#191 Quality Control in the Design and Implementation of a Multi-Site, Prospective, Randomized Controlled Trial of Group Behavioral Treatment for Urinary Incontinence in Older Women

Presenter: Tomas Griebling

#192 Group physiotherapy compared to individual physiotherapy to treat urinary incontinence in aging women: Design and methods of a non-inferiority randomised controlled trial.

Presenter: Yvonne Ruella

#193 Transforming community-based urinary continence promotion: The bowel movement

Presenter: Heidi Brown

#194 Web based patient information on Catheter Treatment www.kateterfakta.nu

Presenter: Marta Lauritzen

#195 Effectiveness of intravesical electrostimulation (IVES) on neurogenic non-obstructive urinary retention: results from a monocentric retrospective study.

Presenter: Oreste Risi

#196 Single-use hydrophilic coated intermittent catheters improve quality of life: Report from a clinical trial on catheter reuse in the United States.

Presenter: Diane Newman

#197 Feasibility of continuous monitoring of the bladder volume by a new portable ultrasound bladder scanner, Lilium α-200

Presenter: Jun Kamei

#198 INNOVATIVE TEXTILE TEHCNOLOGY: PRELIMINARY TESTS ON ANTIMICROBIAL PROPERTIES OF UPEC MICROORGANISMS

Presenter: Marco Soligo

#199 Incontinence Associated Dermatitis in hospitalized patients: prevalence and associated factors.

Presenter: Vera Lúcia Conceição Gouveia Santos

#200 Overactive bowel (OAB) syndrome in mixed urinary incontinence: 2nd) Can it be treated dynamically and mechanically by an intravaginal device?

Presenter: Bernard Guerquin

#201 Early experiences with the adjustable artificial urinary sphincter Zephyr ZSI 375 Version 1.0 and 2.0

Presenter: Tobias Pottek

#202 A-B-Pee: how many can read of those we want to treat?

Presenter: Florine Schlatmann

#203 MANAGEMENT OF LOWER URINARY TRACT DYSFUNCTION IN ACUTE CARE: WHAT IS IMPORTANT FOR MEDICAL STAFFS TO GET MORE APPROPRIATE BEHAVIOR ?

Presenter: Yoko Yoshikawa

#204 Management of lower urinary tract symptoms associated with benign prostatic hyperplasia in elderly patients with a new diagnostic, therapeutic and care pathway

Presenter: Andrea Fuschi

#205 Antimuscarinics and cognition – can we detect a “real-life” association?

Presenter: Kathleen Hunter

#206 Measuring gait variables using motion capture in older women with urinary urgency: a pilot study.

Presenter: William Gibson

#207 Relationship between overactive bladder and comprehensive physical and phycological function in the frail elderly

Presenter: Masaki Yoshida

#208 IPSS Normative Values for Healthy Older Adults Living in the UK

Presenter: Lorna Booth

#209 Comparison of active stimulating electrodes of sacral neuromodulation

Presenter: Xin Su